Ngā hua rapu kaituhi

1

Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor mā Francis S. Willard, Kyle W. Sloop

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor mā Francis S. Willard, Ana B. Bueno, Kyle W. Sloop

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

How May GIP Enhance the Therapeutic Efficacy of GLP-1? mā Ricardo J. Samms, Matthew P. Coghlan, Kyle W. Sloop

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

The current state of <scp>GPCR</scp>‐based drug discovery to treat metabolic disease mā Kyle W. Sloop, Paul J. Emmerson, Michael A. Statnick, Francis S. Willard

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery mā Daniel A. Briere, Ana B. Bueno, Ellen J. Gunn, M. Dodson Michael, Kyle W. Sloop

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Orforglipron (<scp>LY3502970</scp>), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐... mā Edward Pratt, Xiaosu Ma, Rong Liu, Deborah Robins, Tamer Coşkun, Kyle W. Sloop, Axel Haupt, Charles T. Benson

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Orforglipron (<scp>LY3502970</scp>), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐a... mā Edward Pratt, Xiaosu Ma, Rong Liu, Deborah Robins, Axel Haupt, Tamer Coşkun, Kyle W. Sloop, Charles T. Benson

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Differential Activation of Pituitary Hormone Genes by Human Lhx3 Isoforms with Distinct DNA Binding Properties mā Kyle W. Sloop, Bradley C. Meier, JeAnne L. Bridwell, Gretchen E. Parker, Amy McCutchan Schiller, Simon J. Rhodes

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production mā Lucy S. Jun, Rohn Millican, Eric D. Hawkins, Debra L. Konkol, Aaron D. Showalter, Michael E. Christe, M. Dodson Michael, Kyle W. Sloop

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles mā Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Cynthia Stutsman, Aranzazu Marín, James Ficorilli, Over Cabrera, Francis S. Willard, Kyle W. Sloop

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP mā Lawrence J. Slieker, Kyle W. Sloop, Peggy L. Surface, Aidas Kriauciunas, Frank LaQuier, Joseph Manetta, Julie M Bue-Valleskey, Thomas W. Stephens

I whakaputaina 1996

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy mā Darline Garibay, Anne K. McGavigan, Seon A Lee, James Ficorilli, Amy L. Cox, M. Dodson Michael, Kyle W. Sloop, Bethany P. Cummings

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Uncoupling Protein 3 (UCP3) Stimulates Glucose Uptake in Muscle Cells through a Phosphoinositide 3-Kinase-dependent Mechanism mā Christine Huppertz, Britta Fischer, Young‐Bum Kim, Ko Kotani, Antonio Vidal‐Puig, Lawrence J. Slieker, Kyle W. Sloop, Bradford B. Lowell, Barbara B. Kahn

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Regulation of the Follicle-Stimulating Hormone β Gene by the LHX3 LIM-Homeodomain Transcription Factor mā Brooke E. West, Gretchen E. Parker, Jesse J. Savage, Parinda Kiratipranon, Katherine S. Toomey, Lisa R. Beach, Stephanie C. Colvin, Kyle W. Sloop, Simon J. Rhodes

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Insulin and Glucagon: Partners for Life mā Jens J. Holst, William L. Holland, Jesper Gromada, Young Lee, Roger H. Unger, Hai Yan, Kyle W. Sloop, Timothy J. Kieffer, Nicolas Damond, Pedro L. Herrera

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers mā Matthijs K. C. Hesselink, H. A. Keizer, Lars B. Borghouts, Gert Schaart, C.F.P. Kornips, Lawrence J. Slieker, Kyle W. Sloop, Wim H. M. Saris, Patrick Schrauwen

I whakaputaina 2001

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner mā Yanqing Zhang, Keshab R. Parajuli, Genevieve E. Fava, R. C. Gupta, Weiwei Xu, Lauren U. Nguyen, Anadil F. Zakaria, Vivian Fonseca, Hongjun Wang, Franck Mauvais‐Jarvis, Kyle W. Sloop, Hongju Wu

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes mā Yanfang Liu, M. Dodson Michael, Shera Kash, William R. Bensch, Brett P. Monia, Susan F. Murray, Keith A. Otto, Samreen K. Syed, Sanjay Bhanot, Kyle W. Sloop, John M. Sullivan, Anne Reifel‐Miller

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Reduction of Low Molecular Weight Protein-tyrosine Phosphatase Expression Improves Hyperglycemia and Insulin Sensitivity in Obese Mice mā Sanjay K. Pandey, Xing Yu, Lynnetta M. Watts, M. Dodson Michael, Kyle W. Sloop, Amber R. Rivard, Thomas A. Leedom, Vara Prasad Manchem, Laura Samadzadeh, Robert A. McKay, Brett P. Monia, Sanjay Bhanot

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue mā Ricardo J. Samms, Guofang Zhang, Wentao He, Olga Ilkayeva, Brian A. Droz, Steven M. Bauer, Cynthia Stutsman, Valentina Pirro, Kyla Collins, Ellen C Furber, Tamer Coşkun, Kyle W. Sloop, Joseph T. Brozinick, Christopher B. Newgard

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Kyle W. Sloop

Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor mā Francis S. Willard, Kyle W. Sloop

Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor mā Francis S. Willard, Ana B. Bueno, Kyle W. Sloop

How May GIP Enhance the Therapeutic Efficacy of GLP-1? mā Ricardo J. Samms, Matthew P. Coghlan, Kyle W. Sloop

The current state of <scp>GPCR</scp>‐based drug discovery to treat metabolic disease mā Kyle W. Sloop, Paul J. Emmerson, Michael A. Statnick, Francis S. Willard

Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery mā Daniel A. Briere, Ana B. Bueno, Ellen J. Gunn, M. Dodson Michael, Kyle W. Sloop

Differential Activation of Pituitary Hormone Genes by Human Lhx3 Isoforms with Distinct DNA Binding Properties mā Kyle W. Sloop, Bradley C. Meier, JeAnne L. Bridwell, Gretchen E. Parker, Amy McCutchan Schiller, Simon J. Rhodes

Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production mā Lucy S. Jun, Rohn Millican, Eric D. Hawkins, Debra L. Konkol, Aaron D. Showalter, Michael E. Christe, M. Dodson Michael, Kyle W. Sloop

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles mā Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Cynthia Stutsman, Aranzazu Marín, James Ficorilli, Over Cabrera, Francis S. Willard, Kyle W. Sloop

Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP mā Lawrence J. Slieker, Kyle W. Sloop, Peggy L. Surface, Aidas Kriauciunas, Frank LaQuier, Joseph Manetta, Julie M Bue-Valleskey, Thomas W. Stephens

β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy mā Darline Garibay, Anne K. McGavigan, Seon A Lee, James Ficorilli, Amy L. Cox, M. Dodson Michael, Kyle W. Sloop, Bethany P. Cummings

Uncoupling Protein 3 (UCP3) Stimulates Glucose Uptake in Muscle Cells through a Phosphoinositide 3-Kinase-dependent Mechanism mā Christine Huppertz, Britta Fischer, Young‐Bum Kim, Ko Kotani, Antonio Vidal‐Puig, Lawrence J. Slieker, Kyle W. Sloop, Bradford B. Lowell, Barbara B. Kahn

Regulation of the Follicle-Stimulating Hormone β Gene by the LHX3 LIM-Homeodomain Transcription Factor mā Brooke E. West, Gretchen E. Parker, Jesse J. Savage, Parinda Kiratipranon, Katherine S. Toomey, Lisa R. Beach, Stephanie C. Colvin, Kyle W. Sloop, Simon J. Rhodes

Insulin and Glucagon: Partners for Life mā Jens J. Holst, William L. Holland, Jesper Gromada, Young Lee, Roger H. Unger, Hai Yan, Kyle W. Sloop, Timothy J. Kieffer, Nicolas Damond, Pedro L. Herrera

Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers mā Matthijs K. C. Hesselink, H. A. Keizer, Lars B. Borghouts, Gert Schaart, C.F.P. Kornips, Lawrence J. Slieker, Kyle W. Sloop, Wim H. M. Saris, Patrick Schrauwen

Ngā utauta rapu:

Ngā marau whai pānga